Stresser, David M.
30  results:
Search for persons X
?
5

Validation of cocktail enzyme assay in 96-well plated human..:

Choughule, Kankika V. ; Ho, Thuy ; Wang, Duan...
Drug Metabolism and Pharmacokinetics.  33 (2018)  1 - p. S61 , 2018
 
?
6

Reversible and time-dependent inhibition (TDI) of CYP1A2, C..:

Zhang, J. George ; Ho, Thuy ; Patel, Reena...
Drug Metabolism and Pharmacokinetics.  32 (2017)  1 - p. S57-S58 , 2017
 
?
9

In vitro and pharmacophore insights into CYP3A enzymes:

Ekins, Sean ; Stresser, David M. ; Andrew Williams, J.
Trends in Pharmacological Sciences.  24 (2003)  4 - p. 161-166 , 2003
 
?
11

Fluorometric High‐Throughput Screening for Inhibitors of Cy..:

MILLER, VAUGHN P. ; STRESSER, DAVID M. ; BLANCHARD, ANDREW P...
Annals of the New York Academy of Sciences.  919 (2000)  1 - p. 26-32 , 2000
 
?
12

Fluorometric screening for metabolism-based drug–drug inter..:

Crespi, Charles L. ; Stresser, David M.
Journal of Pharmacological and Toxicological Methods.  44 (2000)  1 - p. 325-331 , 2000
 
?
 
?
14

Influence of β-Naphthoflavone and Methoxychlor Pretreatment..:

Schlenk, Daniel ; Stresser, David M. ; McCants, John C...
Toxicology and Applied Pharmacology.  145 (1997)  2 - p. 349-356 , 1997
 
1-15